Financial Ratios Aster DM Quality Care Limited
Stocks
ASTERDM
INE914M01019
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 820.35 INR | +1.02% |
|
+1.47% | +33.06% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.32 | 4.36 | 3.58 | 1.36 | 2.63 | |||||
Return on Total Capital | 3.1 | 5.83 | 4.91 | 2.64 | 5.34 | |||||
Return On Equity % | 4.71 | 14.45 | 10.18 | 4.14 | 7.76 | |||||
Return on Common Equity | 4.45 | 14.36 | 10.12 | 2.72 | 7.68 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.76 | 35.77 | 34.71 | 53.42 | 55.38 | |||||
SG&A Margin | 9.34 | 10.29 | 11.64 | 26.58 | 26.58 | |||||
EBITDA Margin % | 9.38 | 11.81 | 10.17 | 14.41 | 17.06 | |||||
EBITA Margin % | 5.59 | 8.57 | 6.96 | 10.02 | 12.76 | |||||
EBIT Margin % | 5.2 | 8.23 | 6.59 | 9.68 | 12.48 | |||||
Income From Continuing Operations Margin % | 2.07 | 5.86 | 3.98 | 5.53 | 8.14 | |||||
Net Income Margin % | 1.72 | 5.13 | 3.56 | 3.5 | 129.95 | |||||
Net Avail. For Common Margin % | 1.72 | 5.13 | 3.56 | 3.31 | 7.41 | |||||
Normalized Net Income Margin | 1.14 | 3.14 | 2.35 | 2.18 | 7.02 | |||||
Levered Free Cash Flow Margin | 9.95 | 2.16 | 2.38 | -62.78 | 51.96 | |||||
Unlevered Free Cash Flow Margin | 12.08 | 3.72 | 4.09 | -60.99 | 53.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.71 | 0.85 | 0.87 | 0.23 | 0.34 | |||||
Fixed Assets Turnover | 1.33 | 1.57 | 1.65 | 0.68 | 1.19 | |||||
Receivables Turnover (Average Receivables) | 3.87 | 5.01 | 5.37 | 2.79 | 15.08 | |||||
Inventory Turnover (Average Inventory) | 6.11 | 6.81 | 6.29 | 2.22 | 14.68 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.14 | 1.15 | 1.06 | 1.25 | 2.16 | |||||
Quick Ratio | 0.73 | 0.68 | 0.6 | 0.03 | 0.61 | |||||
Operating Cash Flow to Current Liabilities | 0.49 | 0.37 | 0.39 | 0.01 | 0.48 | |||||
Days Sales Outstanding (Average Receivables) | 94.35 | 72.91 | 67.98 | 130.98 | 24.2 | |||||
Days Outstanding Inventory (Average Inventory) | 59.78 | 53.6 | 58.06 | 164.62 | 24.87 | |||||
Average Days Payable Outstanding | 135.56 | 111.52 | 114.52 | 1.41K | 88.58 | |||||
Cash Conversion Cycle (Average Days) | 18.57 | 15 | 11.52 | -1.11K | -39.51 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 125.9 | 110.45 | 117.56 | 27.51 | 55.26 | |||||
Total Debt / Total Capital | 55.73 | 52.48 | 54.03 | 21.57 | 35.59 | |||||
LT Debt/Equity | 105.1 | 87.88 | 91.9 | 22.59 | 50.1 | |||||
Long-Term Debt / Total Capital | 46.53 | 41.76 | 42.24 | 17.72 | 32.27 | |||||
Total Liabilities / Total Assets | 67.07 | 64.27 | 67.34 | 72.04 | 44.73 | |||||
EBIT / Interest Expense | 1.53 | 3.31 | 2.42 | 3.38 | 4.8 | |||||
EBITDA / Interest Expense | 3.62 | 5.77 | 4.76 | 5.45 | 7.12 | |||||
(EBITDA - Capex) / Interest Expense | 2.23 | 3.88 | 2.55 | -2.06 | 3.9 | |||||
Total Debt / EBITDA | 4.57 | 3.36 | 3.69 | 2.39 | 2.64 | |||||
Net Debt / EBITDA | 4.29 | 3.11 | 3.44 | 2.21 | 2.42 | |||||
Total Debt / (EBITDA - Capex) | 7.4 | 5.01 | 6.88 | -6.33 | 4.81 | |||||
Net Debt / (EBITDA - Capex) | 6.95 | 4.63 | 6.4 | -5.84 | 4.41 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.5 | 19.11 | 16.38 | 23.54 | 11.88 | |||||
Gross Profit, 1 Yr. Growth % | -4.11 | 26.19 | 12.95 | 26.75 | 16 | |||||
EBITDA, 1 Yr. Growth % | -21 | 50.04 | 0.26 | 29.95 | 32.45 | |||||
EBITA, 1 Yr. Growth % | -30.62 | 82.43 | -5.5 | 39.41 | 42.51 | |||||
EBIT, 1 Yr. Growth % | -33.91 | 88.58 | -6.84 | 39.36 | 44.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -43.49 | 237.99 | -20.89 | 28.25 | 64.5 | |||||
Net Income, 1 Yr. Growth % | -46.59 | 256.02 | -19.22 | -69.57 | 4.06K | |||||
Normalized Net Income, 1 Yr. Growth % | -46.62 | 229.37 | -13.13 | 13.18 | 259.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -46 | 255.89 | -19.3 | 12.58 | 149.97 | |||||
Accounts Receivable, 1 Yr. Growth % | -15.54 | 1.04 | 15.88 | -89.03 | 9.77 | |||||
Inventory, 1 Yr. Growth % | -13.16 | 22.81 | 32.48 | -90.26 | -17.08 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.95 | 4.07 | 17.52 | -60.92 | 28.48 | |||||
Total Assets, 1 Yr. Growth % | -6.39 | 7.75 | 18.61 | 20.9 | -63.28 | |||||
Tangible Book Value, 1 Yr. Growth % | 4.2 | 24.98 | 12.87 | 46.02 | -26.51 | |||||
Common Equity, 1 Yr. Growth % | 3.07 | 17.23 | 12.51 | 2.51 | -24.82 | |||||
Cash From Operations, 1 Yr. Growth % | 28.27 | -16.29 | 39.57 | -91.4 | 169.34 | |||||
Capital Expenditures, 1 Yr. Growth % | -22.83 | 19.49 | 48.4 | 11.17 | -56.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 183.44 | -74.13 | 28.38 | 378.71 | -191.79 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 108.49 | -63.34 | 28.05 | 422.35 | -197.42 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | 150 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.98 | 8.86 | 17.74 | -39.94 | 17.57 | |||||
Gross Profit, 2 Yr. CAGR % | 3 | 10 | 19.38 | -26.6 | 21.25 | |||||
EBITDA, 2 Yr. CAGR % | -3.06 | 8.87 | 22.65 | -33.66 | 31.19 | |||||
EBITA, 2 Yr. CAGR % | -8.12 | 12.51 | 31.3 | -35.03 | 40.95 | |||||
EBIT, 2 Yr. CAGR % | -10.42 | 11.64 | 32.54 | -34.85 | 41.77 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -30.42 | 38.21 | 63.52 | -41.64 | 45.25 | |||||
Net Income, 2 Yr. CAGR % | -33.4 | 37.9 | 69.59 | -50.42 | 255.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | -33.63 | 32.59 | 69.15 | -49.93 | 101.69 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -33.02 | 38.63 | 69.47 | -51.75 | 67.76 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.36 | -7.62 | 8.2 | -64.35 | -65.3 | |||||
Inventory, 2 Yr. CAGR % | 6.99 | 3.27 | 27.55 | -64.08 | -71.58 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 28.37 | 0.5 | 10.59 | -32.23 | -29.14 | |||||
Total Assets, 2 Yr. CAGR % | 14.15 | 0.43 | 13.05 | 19.75 | -33.37 | |||||
Tangible Book Value, 2 Yr. CAGR % | -4.02 | 14.12 | 18.77 | 28.38 | 3.59 | |||||
Common Equity, 2 Yr. CAGR % | 2.44 | 9.92 | 14.85 | 7.4 | -12.21 | |||||
Cash From Operations, 2 Yr. CAGR % | 61.59 | 3.62 | 8.11 | -65.35 | -51.86 | |||||
Capital Expenditures, 2 Yr. CAGR % | -15.61 | -3.98 | 33.16 | 28.44 | -30.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 45.84 | -14.37 | -42.37 | 223.65 | 110.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 85.05 | -12.57 | -31.48 | 143.29 | 126.6 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.6 | 8.79 | 11.31 | -24.54 | -26.1 | |||||
Gross Profit, 3 Yr. CAGR % | 8.26 | 10.21 | 10.98 | -12.07 | -14.5 | |||||
EBITDA, 3 Yr. CAGR % | 9.69 | 12.13 | 5.92 | -12.92 | -16.47 | |||||
EBITA, 3 Yr. CAGR % | 13.31 | 15.48 | 6.15 | -8.34 | -15.59 | |||||
EBIT, 3 Yr. CAGR % | 11.79 | 14.81 | 5.1 | -7.15 | -15.09 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -14.22 | 17.84 | 14.75 | 4.8 | -17.57 | |||||
Net Income, 3 Yr. CAGR % | -18.09 | 16.45 | 15.38 | -4.35 | 117.04 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.24 | 13.21 | 15.16 | -6.19 | -3.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -19.72 | 16.88 | 15.75 | -6.08 | -16.52 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.57 | 0.1 | -0.37 | -49.55 | -48.14 | |||||
Inventory, 3 Yr. CAGR % | 10.47 | 12.02 | 12.21 | -45.89 | -52.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 23.75 | 19.7 | 5.88 | -21.81 | -16.12 | |||||
Total Assets, 3 Yr. CAGR % | 15.87 | 11.97 | 6.16 | 15.61 | -19.25 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.18 | 4.81 | 13.7 | 27.24 | 6.59 | |||||
Common Equity, 3 Yr. CAGR % | 5.99 | 7.15 | 10.78 | 10.58 | -4.64 | |||||
Cash From Operations, 3 Yr. CAGR % | 42.93 | 29.78 | 14.45 | -53.5 | -31.35 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.88 | -5.24 | 11.02 | 25.39 | -10.52 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 42.58 | -18.06 | -2 | 39.41 | 113.27 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 76.9 | 7.88 | -0.71 | 29.47 | 79.86 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.4 | 11.57 | 12.17 | -14.22 | -13.71 | |||||
Gross Profit, 5 Yr. CAGR % | 8.45 | 13.91 | 12.58 | -6.33 | -5.44 | |||||
EBITDA, 5 Yr. CAGR % | 12.15 | 29.45 | 14.7 | -9.1 | -7.13 | |||||
EBITA, 5 Yr. CAGR % | 17.03 | 107.76 | 20.19 | -8.25 | -5.31 | |||||
EBIT, 5 Yr. CAGR % | 15.63 | 118.66 | 19.67 | -8.47 | -5.27 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 84.98 | 43.86 | 11.04 | -11.04 | 1.36 | |||||
Net Income, 5 Yr. CAGR % | 20.15 | 38.89 | 9.58 | -17.25 | 81.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.34 | 11.4 | 23.57 | -18.32 | 9.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 17.05 | 37 | 8.24 | -17.96 | 2.26 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.51 | 6.67 | 8.42 | -33.77 | -34.67 | |||||
Inventory, 5 Yr. CAGR % | 13.05 | 14.76 | 17.01 | -28.92 | -35.22 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 21.64 | 16.79 | 18.31 | -4.66 | -9.83 | |||||
Total Assets, 5 Yr. CAGR % | 15.13 | 13.01 | 14.74 | 15.02 | -11.89 | |||||
Tangible Book Value, 5 Yr. CAGR % | 110.19 | 19.57 | 7.24 | 13.67 | 9.54 | |||||
Common Equity, 5 Yr. CAGR % | 51.71 | 16.89 | 9.45 | 7.25 | 0.94 | |||||
Cash From Operations, 5 Yr. CAGR % | 50.58 | 29.49 | 27.83 | -23.46 | -19.06 | |||||
Capital Expenditures, 5 Yr. CAGR % | -11.49 | -12.18 | 6.75 | 7.02 | -7.96 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.98 | -22.07 | -0.76 | 41.95 | 48.05 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.57 | -8.1 | 21.05 | 49.35 | 34.78 |
- Stock Market
- Stocks
- ASTERDM Stock
- Financials Aster DM Quality Care Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















